# Bolt Biotherapeutics, Inc.: Form DEF 14A, filed Apr 28, 2023

- Company: [Bolt Biotherapeutics, Inc.](/companies/bolt.md) (CIK 1641281)
- Form: DEF 14A
- Filed: 2023-04-28
- Accepted by EDGAR: Apr 28, 2023, 16:09 ET
- Period: 2023-06-12
- Accession: 0000950170-23-015790
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1641281/000095017023015790/2023_bolt_def_14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1641281/000095017023015790/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1641281/000095017023015790/2023_bolt_def_14a.htm

Filed Apr 28, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-015790. Last ingested by Listed: Oct 27, 2026, 17:22 ET. No prices; not investment advice.